Search - Leibniz Institute for Prevention Research and Epidemiology

241. [BIPS Project] Care-related factors associated with antepartal diagnosis of intrauterine growth restrictions (BIUS) - A case-control study

URL: /en/research/projects/detail-view.html?projID=445&cHash=39c813c4703bd012a9231bdd9db7880f
Date: 01-03-12

Antenatal care is of core importance for maternal and child health and is therefore a central aspect of mother and child health care. One of the main goals of effective screening in antenatal care is…

242. [BIPS Project] Determinants of eating behaviour in European children, adolescents and their parents - I.Family study

URL: /en/research/projects/detail-view.html?projID=360&cHash=e6a7f0a8bb34b5fb6538c614f2f73703
Date: 01-03-12

You are what you eat and the way that you eat it! The EC-funded project I.Family aimed to do just that, helping to identify the reasons why young people in Europe eat the way they do and how this…

243. [BIPS Project] Two-phase methodology for the combined analysis of secondary data sources

URL: /en/research/projects/detail-view.html?projID=466&cHash=a95d64bf728dce406857c82139a34453
Date: 11-05-12

Administrative data of statutory health insurances are a valuable data source for pharmacoepidemiological studies and health services research. The validity of studies based on these data might be…

244. [BIPS Project] Pharmacoepidemiological safety study of neuroleptics and antidepressants in the area of geriatric psychiatrics

URL: /en/research/projects/detail-view.html?projID=476&cHash=2613c1f6f9a8f2ef0c8cc0c397ee5124
Date: 01-11-12

More than half of Germans aged 65 and older are treated with antipsychotics or antidepressants despite of concerns that the use of these drugs in this population is associated with an increase in…

245. [BIPS Project] Drug safety in children and adolescents (a) off-label use and safety of neuroleptic and antidepressive medication, (b) safety of psycho-stimulant therapy

URL: /en/research/projects/detail-view.html?projID=475&cHash=136233cc6b32a1b221c0abfee0baa5e3
Date: 01-11-12

In paediatric populations, drugs are frequently prescribed off-label (not in accordance with the approved age range or indications). This is also true for psychotropic drugs. Studies found that up to…

246. [BIPS Project] European medical information framework

URL: /en/research/projects/detail-view.html?projID=473&cHash=f62456abfee248c8bd7c9b1a0b81e333
Date: 01-01-13

In Europe, a considerable number of data bases exist, which include patient health information. However, these data are commonly stored in a fragmented way in different systems and locations, thereby…

247. [BIPS Project] Cohort study of the relative incidence of major cardiovascular events (MACE) among patients initiating prucalopride versus a matched comparator cohort

URL: /en/research/projects/detail-view.html?projID=560&cHash=22c3fceef2b414d95861c6de5f2a786d
Date: 23-04-13

Prucalopride (Resolor®) is a new selective 5-HAT4 agonist and was approved in Europe in October 2009 as first agent of its drug class for the treatment of chronic constipation in women in which…

248. [BIPS Project] Determinants of diet and physical activity (DEDIPAC), Knowledge Hub to integrate and develop infrastructure for research across Europe

URL: /en/research/projects/detail-view.html?projID=556&cHash=bb807119f88ade00a484fc296c686395
Date: 01-12-13

The Determinants of Diet and Physical Activity (DEDIPAC) Knowledge Hub was established as part of the Joint Programming Initiative ‘A Healthy Diet for a Healthy Life’ which was launched by the…

249. [BIPS Project] Microbiome influence on energy balance and brain development-function put into action to tackle diet-related diseases and behavior (MyNewGut)

URL: /en/research/projects/detail-view.html?projID=541&cHash=c474ca122b33b13021830f4b78d0d87d
Date: 01-12-13

Emerging evidence indicates that the gut microbiome contributes to our ability to extract energy from the diet and influences development and function of the immune, endocrine and nervous systems,…

250. [BIPS Project] Post-authorization safety study on agomelatine and the risk of hospitalization for acute liver injury

URL: /en/research/projects/detail-view.html?projID=614&cHash=d6fb320a906b37e1962b34f47eea3ffd
Date: 15-08-14

Agomelatine (Valdoxan, Thymanax) is a melatonergic agonist and 5-HT2C antagonist which is, among other antidepressants, indicated for major depressive episodes in adults. Its marketing authorisation…